---
title: Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1-positive
  acute lymphoblastic leukemia
date: '2024-06-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38917352/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240626181628&v=2.18.0.post9+e462414
source: Blood
description: Tyrosine kinase inhibitors have improved outcomes in Philadelphia-positive
  ALL, but their efficacy in CNS disease remains uncertain. Ponatinib was studied
  for CNS distribution in 22 samples from 16 patients. CSF concentrations fell below
  the 40nM threshold, suggesting suboptimal CNS ...
disable_comments: true
---
Tyrosine kinase inhibitors have improved outcomes in Philadelphia-positive ALL, but their efficacy in CNS disease remains uncertain. Ponatinib was studied for CNS distribution in 22 samples from 16 patients. CSF concentrations fell below the 40nM threshold, suggesting suboptimal CNS ...